Tag: SARS-CoV-2

New SARS-CoV-2 variant BA.2.86 detected: UKHSA releases initial risk assessment amid global concerns

businessnewstoday- August 19, 2023

The UK Health Security Agency (UKHSA) has unveiled its preliminary risk analysis of the SARS-CoV-2 variant BA.2.86, a strain first detected in the UK on ... Read More

Nasodine Nasal Spray phase 3 clinical trial : Firebrick Pharma completes 82% patient recruitment

businessnewstoday- May 31, 2023

Firebrick Pharma, an ASX-listed pharmaceutical company, announced that it has successfully enrolled 160 subjects in the confirmatory phase 3 clinical trial of Nasodine Nasal Spray ... Read More

Pfizer gets PAXLOVID FDA approval for COVID-19 in high-risk adults

businessnewstoday- May 25, 2023

Pfizer has obtained approval for PAXLOVID, an oral combination therapy of nirmatrelvir tablets and ritonavir tablets, from the US Food and Drug Administration (FDA) to ... Read More

AstraZeneca strikes licensing deal with RQ Bio for SARS-CoV-2 targeting mAbs

pallavi123- May 18, 2022

AstraZeneca has signed a licensing deal with RQ Biotechnology (RQ Bio) to gain access to a portfolio of early-stage monoclonal antibodies (mAbs) targeted against Covid-19 ... Read More

AstraZeneca gets UK MHRA approval for Evusheld for Covid-19 prevention

pallavi123- March 18, 2022

AstraZeneca said that its antibody combination Evusheld (tixagevimab co-packaged with cilgavimab) has been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

pallavi123- March 18, 2022

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

Sorrento Therapeutics acquires majority stake in Zhengzhou FortuneBio

businessnewstoday- February 20, 2022

Sorrento Therapeutics has acquired a majority stake in Zhengzhou Fortune Bioscience (Zhengzhou FortuneBio), a Chinese diagnostic manufacturer, for an undisclosed price. According to Sorrento Therapeutics, ... Read More

Lilly gets FDA EUA for bebtelovimab in mild-to-moderate Covid-19

pallavi123- February 12, 2022

Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of ... Read More

Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India

pallavi123- February 9, 2022

Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter's Nitric Oxide Nasal Spray under the brand name FabiSpray in ... Read More

Celltrion files IND for phase 3 trial of inhaled Covid-19 cocktail therapy

pallavi123- February 7, 2022

Celltrion Group (Celltrion Healthcare), a South Korean pharma company, has submitted an investigational new drug (IND) application to carry out a global phase 3 clinical ... Read More